Dr. Laura Muñoz Moreno joined the Biochemistry and Molecular Biology Department in University of Alcalá in Madrid (Spain), to develop his PhD studies in protate cancer therapeutics, in 2009. She received her Master’s degree in Cellular Signaling from University of Alcalá in 2010. During her PhD studies, she spent 3 months at the CABIMER in Sevilla (Spain). She obtained her PhD degree in Biology from the Faculty of Biology of the University of Alcalá in 2015. Then, she continued until Diciembre 2016 with a post-doctoral position in the same group in University os Alcalá where she worked in dendrimers and naoconjugated of dendrimer-peptide as anticancer agents against prostate cancer. In 2016 she joined the FIOBI group at the Hospital Universitario La Paz-IdiPaz (HULP-IdiPAZ), as a postdoctoral researcher.